Janus Henderson Group PLC Harmony Biosciences Holdings, Inc. Transaction History

Janus Henderson Group PLC

$188 Billion
Q4 2024

A detailed history of Janus Henderson Group PLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 221,063 shares of HRMY stock, worth $7.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

221,063

Previous 168,500 31.19%

Holding current value

$7.37 Million

Previous $6.73 Million 13.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$31.86 - $41.49 $1.67 Million - $2.18 Million	52,563 Added 31.19%	221,063 $7.61 Million
Q3 2024 Nov 14, 2024	SELL	$30.0 - $39.95 $296,010 - $394,186	-9,867 Reduced 5.53%	168,500 $6.73 Million
Q2 2024 Aug 14, 2024	SELL	$28.81 - $33.01 $193,487 - $221,695	-6,716 Reduced 3.63%	178,367 $5.38 Million
Q1 2024 May 15, 2024	BUY	$29.93 - $35.06 $5.04 Million - $5.91 Million	168,434 Added 1011.68%	185,083 $6.22 Million
Q4 2023 Feb 14, 2024	SELL	$19.2 - $33.78 $787 - $1,384	-41 Reduced 0.25%	16,649 $537,000
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $127 - $156	4 Added 0.02%	16,690 $546,000
Q2 2023 Aug 14, 2023	SELL	$30.5 - $37.4 $1.06 Million - $1.3 Million	-34,691 Reduced 67.52%	16,686 $587,000
Q1 2023 May 15, 2023	SELL	$30.8 - $53.92 $38.2 Million - $66.9 Million	-1,240,758 Reduced 96.02%	51,377 $1.68 Million
Q4 2022 Feb 14, 2023	SELL	$45.4 - $60.91 $10.1 Million - $13.6 Million	-222,968 Reduced 14.72%	1,292,135 $71.2 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $3.78 Million - $4.99 Million	89,935 Added 6.31%	1,515,103 $67.1 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $6.03 Million - $9.37 Million	-179,741 Reduced 11.2%	1,425,168 $69.5 Million
Q1 2022 May 16, 2022	BUY	$33.14 - $51.13 $2.03 Million - $3.13 Million	61,185 Added 3.96%	1,604,909 $78.1 Million
Q4 2021 Feb 14, 2022	BUY	$34.09 - $43.91 $11.1 Million - $14.2 Million	324,165 Added 26.58%	1,543,724 $65.8 Million
Q3 2021 Nov 16, 2021	SELL	$25.68 - $38.61 $1.07 Million - $1.62 Million	-41,833 Reduced 3.32%	1,219,559 $46.7 Million
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $2.79 Million - $3.6 Million	107,609 Added 9.33%	1,261,392 $35.6 Million
Q1 2021 May 17, 2021	BUY	$27.56 - $40.37 $1.64 Million - $2.4 Million	59,334 Added 5.42%	1,153,783 $38.1 Million
Q4 2020 Feb 16, 2021	BUY	$31.74 - $51.34 $6.97 Million - $11.3 Million	219,540 Added 25.09%	1,094,449 $39.6 Million
Q3 2020 Nov 16, 2020	BUY	$30.96 - $44.39 $27.1 Million - $38.8 Million	874,909 New	874,909 $29.7 Million

Others Institutions Holding HRMY

# of Institutions

255

Shares Held

46.7M

Call Options Held

119K

Put Options Held

50K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.97B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Harmony Biosciences Holdings, Inc. Transaction History